PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
1-Year Return
49.19%
This Quarter Return
+9.51%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$94.7M
AUM Growth
+$5.36M
(+6%)
Cap. Flow
+$2.2M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9
Top Buys
| 1 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
$1.92M |
| 2 |
SkyWater Technology
SKYT
|
$995K |
| 3 |
8x8 Inc
EGHT
|
$901K |
| 4 |
Usio Inc
USIO
|
$467K |
| 5 |
Quest Diagnostics
DGX
|
$231K |
Top Sells
| 1 |
CareDx
CDNA
|
$969K |
| 2 |
UPH
UpHealth, Inc.
UPH
|
$415K |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$335K |
| 4 |
RingCentral
RNG
|
$221K |
| 5 |
QUMU
Qumu Corp.
QUMU
|
$148K |
Sector Composition
| 1 | Healthcare | 56.93% |
| 2 | Technology | 21.82% |
| 3 | Communication Services | 7.13% |
| 4 | Industrials | 6.74% |
| 5 | Consumer Staples | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Inuvo
INUV
$49M
| $1.25M | 1.32% |
564,308
+7,900
| +1% | +$17.5K |
|
27
QuickLogic
QUIK
$84.4M
| $1.22M | 1.29% |
237,535
-2,500
| -1% | -$12.9K |
|
28
Cantaloupe
CTLP
$792M
| $1.2M | 1.26% |
275,350
+10,000
| +4% | +$43.5K |
|
29
Gilead Sciences
GILD
$143B
| $1.19M | 1.25% |
13,817
-500
| -3% | -$42.9K |
|
30
FlexShopper
FPAY
$18.3M
| $1.19M | 1.25% |
1,281,460
-3,480
| -0.3% | -$3.22K |
|
31
Bristol-Myers Squibb
BMY
$96B
| $1.13M | 1.19% |
15,641
| – | – |
|
32
Target
TGT
$42.3B
| $1.11M | 1.18% |
7,475
-254
| -3% | -$37.9K |
|
33
Elutia
ELUT
$79.7M
| $1.1M | 1.16% |
259,079
+40,750
| +19% | +$173K |
|
|
PDCO
34
DELISTED
Patterson Companies, Inc.
PDCO
| $1M | 1.06% |
35,770
-180
| -0.5% | -$5.05K |
|
|
35
SkyWater Technology
SKYT
$491M
| $995K | 1.05% |
+140,000
| New | +$995K |
|
36
Vericel Corp
VCEL
$1.72B
| $950K | 1% |
36,067
-300
| -0.8% | -$7.9K |
|
37
Ciena
CIEN
$16.5B
| $918K | 0.97% |
18,000
| – | – |
|
|
38
8x8 Inc
EGHT
$282M
| $901K | 0.95% |
+208,500
| New | +$901K |
|
39
Castle Biosciences
CSTL
$683M
| $732K | 0.77% |
31,110
| – | – |
|
40
3M
MMM
$82.7B
| $727K | 0.77% |
7,250
-90
| -1% | -$9.03K |
|
41
AT&T
T
$212B
| $722K | 0.76% |
39,242
| – | – |
|
42
Perspective Therapeutics
CATX
$257M
| $685K | 0.72% |
277,264
-7,800
| -3% | -$19.3K |
|
43
Verizon
VZ
$187B
| $647K | 0.68% |
16,417
| – | – |
|
44
Exagen
XGN
$213M
| $606K | 0.64% |
252,405
-5,050
| -2% | -$12.1K |
|
45
Apple
AAPL
$3.56T
| $604K | 0.64% |
4,650
| – | – |
|
|
AKTS
46
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $604K | 0.64% |
214,350
-2,100
| -1% | -$5.92K |
|
47
BioLife Solutions
BLFS
$1.27B
| $582K | 0.61% |
32,000
| – | – |
|
48
Donaldson
DCI
$9.44B
| $582K | 0.61% |
9,884
| – | – |
|
49
MDxHealth
MDXH
$175M
| $561K | 0.59% |
84,805
-3
| -0% | -$20 |
|
50
Fortress Biotech
FBIO
$110M
| $539K | 0.57% |
54,834
+2,000
| +4% | +$19.7K |
|